All members were invited to attend the COVID-19 Clinical Research Coalition’s Members Assembly in June, a large participatory online event that was convened for the first time a year after launching the coalition.

The coalition’s Maternal, Newborn, and Child Health Working Group conducted a research priority-setting exercise to identify global research priorities in maternal, reproductive and child health. Members of the working group shared the results in this webinar.

This meeting brought together global research funders with the community of researchers who are actively undertaking this research across low- and middle-income countries.

In this webinar, experts and members of the Clinical Epidemiology Working Group give a brief overview of the response to the COVID-19 pandemic from resource-limited settings.

This webinar, the second in a series on social science research related to vaccine trials, brought together social science and community engagement experts to draw on their experiences from clinical trials during COVID-19 and past epidemics.

Médecins Sans Frontières and the Drugs for Neglected Diseases initiative hosted a webinar to discuss the implications of the TRIPs waiver proposal for Africa, and why countries should support it.

The COVID-19 Clinical Research Coalition and PHEPREN (Public Health Emergency and Response Ethics Network) hosted a webinar to share the findings of a project undertaken in collaboration with the Ethics Working Group to review the challenges and opportunities of ethics review mutual recognition for COVID-19 multi-site research protocols.

ORAS-CONHU hosted a webinar about the COVID-19 Clinical Research Coalition with speakers from the coalition’s Steering Committee and several expert working groups. Available in English and Spanish.

In this webinar, scientists from Brazil, India, Thailand, and the US discuss the ethics, safety, and justification for evaluating hydroxychloroquine and chloroquine to prevent COVID-19, in a context of guidance having been recently issued by the World Health Organization to halt the use of these drugs to treat the disease.

The Social Science Working Group organized a webinar on social science research and community engagement in vaccine clinical trials in low-resource settings. This is the first of a three-webinar series on the social science of vaccine development and deployment.